See also this year's filing and all EDGAR filings for this company.
PDF Report 0001503802_2023_Karyopharm_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001503802, Karyopharm Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 350,162,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,139,000 |
| 3 | remainder_Assets | 6,871,000 |
| 4 | LiabilitiesCurrent | 65,908,000 |
| 5 | LiabilitiesNoncurrent | 6,097,000 |
| 6 | remainder_Liabilities | 302,823,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 148,100,869 |
| 9 | ResearchAndDevelopmentExpense | 149,263,999 |
| 10 | remainder_Expenses | 7,055,133 |
| 11 | remainder_Revenues | 147,270,227 |
| 12 | remainder_NetIncome | -19,180,681 |
| 13 | remainder_ComprehensiveNetIncome | -910,496 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 358,172,000 |
| 1 | Liabilities | 374,828,000 |
| 2 | Expenses | 304,420,001 |
| 3 | Revenues | 147,270,227 |
| 4 | StockholdersEquity | -16,656,000 |
| 5 | NetIncome | -176,330,455 |
| 6 | ComprehensiveNetIncome | -176,785,703 |
| 7 | BaseVar | 602,390,702 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.581 |
| 9 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
